purine/heilablóðfall

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

9 niðurstöður

Purine receptor inhibition as a therapeutic strategy in spinal cord and brain

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF THE INVENTION The present invention is directed to inhibition of purine receptors as a therapeutic strategy in spinal cord and brain injury. BACKGROUND OF THE INVENTION Acute spinal injury is a major public health problem. Spinal cord injuries resulting in paralysis or other severe

Systemic purine administration: modulating axonal outgrowth of central nervous system neurons

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF THE INVENTION The invention relates to methods and compositions for modulating the axonal outgrowth of central nervous system neurons. In particular, the invention provides means of internalized purine administration. BACKGROUND OF THE INVENTION After early childhood, injury to the central

Purine derivatives

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF INVENTION The present invention relates to new 2,6,9-substituted purine derivatives and their biological applications. In particular, the invention relates to purine derivatives having antiproliferative properties which are useful in the treatment of proliferative disorders such as cancer,

Purine derivatives

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Purine derivatives

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

RELATED APPLICATIONS This application is a continuation of PCT/GB2003/003554, filed on Aug. 13, 2003, which claims priority to GB 0219054.4 filed on Aug. 15, 2002. The entire contents of both of these applications are hereby incorporated herein by reference. FIELD OF INVENTION The present invention

Trisubstituted purine derivatives

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Purine derivatives as A3 and A1 adenosine receptor agonists

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF THE INVENTION This invention pertains to A.sub.3 and A.sub.1 adenosine receptor agonists, pharmaceutical compositions comprising such agonists, and a method of use thereof, for example, in treating various medical disorders. BACKGROUND OF THE INVENTION Extracellular adenosine acts as a

Purine derivatives as A.sub.3 adenosine receptor-selective agonists

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND OF THE INVENTION Extracellular adenosine acts as a local modulator at four subtypes of adenosine receptors, namely, A.sub.1, A.sub.2A, A.sub.2B, and A.sub.3, which are involved in numerous physiological and pathophysiological processes. Fredholm et al., Pharmacol. Rev. 2001; 53:527-52.

Methods for treatment using small molecule potassium-sparing diuretics and natriuretics

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD This relates to the field of small molecule PNPase substrates and inhibitors as well as potassium-sparing diuretics and natriuretics and methods of their use. BACKGROUND With the notable exceptions of mineralocorticoid antagonists and epithelial sodium channel (ENaC) inhibitors, most

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum